Chronic hepatitis C, depression and interferon

Journal of Hepatology

Volumn 42, Issue 6, 2005, Pages 788-789

  Horsmans, Yves ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; FLUOXETINE; INTERFERON; PEGINTERFERON; RIBAVIRIN; SEROTONIN UPTAKE INHIBITOR;

DEPRESSION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; EDITORIAL; FOLLOW UP; HEPATITIS C; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; PRIORITY JOURNAL;

ANTIVIRAL AGENTS; DEPRESSIVE DISORDER, MAJOR; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS;

EID: 18844398845     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.03.005     Document Type: Editorial

References (16)

1. M. Schaefer, M. Schwaiger, A.S. Garkisch, M. Pich, A. Hinzpeter, and R. Uebelhack Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C J Hepatol 42 2005 793 798
2. W. Cai, V.I. Khaoustov, Q. Xie, T. Pan, W. Le, and B. Yoffe Interferon-α- induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression J Hepatol 42 2005 880 887
3. K. Weissenborn, J. Krause, M. Bokemeyer, H. Hecker, A. Schüler, and J.C. Ennen Hepatitis C virus infection affects the brain - evidence from psychometric studies and magnetic resonance spectroscopy J Hepatol 41 2004 845 851
4. M.P. Manns, J.G. McHutchinson, S.C. Gordon, V.K. Rustgi, M. Shiffman, and R. Reindollar Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial Lancet 358 2001 958 965
5. S. Zeuzem, M. Diago, E. Gane, K.R. Reddy, P. Pockros, and D. Prati Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase level Gastroenterology 127 2004 1724 1732
6. D.L. Musselman, D.H. Lawson, J.F. Gumnick, A.K. Manatunga, S. Penna, and R.S. Goodkin Paroxetine for the prevention of depression induced by high-dose interferon alfa N Engl J Med 13 2001 961 966
7. C.M. Pariante, M.G. Orrù, A. Baita, M.G. Farci, and B. Carpiniello Treatment with interferon-α in patients with chronic hepatitis and mood or anxiety disorders Lancet 354 1999 131 132
8. G.M. Lauer, and B.D. Walker Hepatitis C virus infection N Engl J Med 345 2001 41 52
9. E. Dieperink, M. Willenbring, and S.B. Ho Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review Am J Psychiatry 157 2000 867 876
10. M.H. Woo, and T.G. Burnakis Interferon alfa in the treatment of chronic viral hepatitis B and C Ann Pharmacother 31 1997 330 337
11. M. Schaefer, F. Schmidt, C. Folwaczny, R. Lorenz, G. Martin, and N. Schindlbeck Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric patients Hepatology 37 2003 443 451
12. T.H. Jones, S. Wadler, and K.H. Hupart Endocrine-mediated mechanisms of fatigue during treatment with interferon-alpha Semin Oncol 25 1998 54 63
13. L. Capuron, C.L. Raison, D.L. Musselman, D.H. Lawson, C.B. Nemeroff, and A.H. Miller Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy Am J Psychiatry 160 2003 1342 1345
14. L. Capuron, G. Neurauter, D.L. Musselman, D.H. Lawson, C.B. Nemeroff, and D. Fuchs Interferon-alpha-induced changes in tryptophan metabolism, relationship to depression and paroxetine treatment Biol Psychiatry 54 2003 906 914
15. S.J. Hadziyannis, and G.V. Papatheodoridis Peginterferon-(2a α40 kDa) for chronic hepatitis C Expert Opin Pharmacother 4 2003 541 551
16. A. Gladkevich, H.F. Kauffman, and J. Korf Lymphocytes as a neural probe: potential for studying psychiatric disorders Prog Neuropsychopharmacol Biol Psychiatry 28 2004 559 576